Evidence map›Paper›PMID 33405003›Full record

ArticleJournal of assisted reproduction and genetics2021

miR-219a suppresses human trophoblast cell invasion and proliferation by targeting vascular endothelial growth factor receptor 2 (VEGFR2).

Guiju Zhou, Zhifang Li, Pin Hu, Jing Wang, Juanjuan Fu, Bing Wei, Yu Zhang

Open access · greenAbstract read
In one paragraph

Article in Journal of assisted reproduction and genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Guiju ZhouDepartment of Obstetrics and Gynecology, The Second Affiliated Hospital, Anhui Medical University, 678 Furong Road, 230000, Hefei, People's Republic of China.
Zhifang LiAnqing Municipal Hospital, Anhui Medical University, Anqing, China.
Pin HuDepartment of Obstetrics and Gynecology, The Second Affiliated Hospital, Anhui Medical University, 678 Furong Road, 230000, Hefei, People's Republic of China.
Jing WangDepartment of Obstetrics and Gynecology, The Second Affiliated Hospital, Anhui Medical University, 678 Furong Road, 230000, Hefei, People's Republic of China.
Juanjuan FuDepartment of Obstetrics and Gynecology, The Second Affiliated Hospital, Anhui Medical University, 678 Furong Road, 230000, Hefei, People's Republic of China.
Bing WeiDepartment of Obstetrics and Gynecology, The Second Affiliated Hospital, Anhui Medical University, 678 Furong Road, 230000, Hefei, People's Republic of China. bingw1@sohu.com.
Yu ZhangDepartment of Obstetrics and Gynecology, The Second Affiliated Hospital, Anhui Medical University, 678 Furong Road, 230000, Hefei, People's Republic of China. zhangy_11@21cn.com.
Anhui Medical University · CNSecond Hospital of Anhui Medical University · CNAnqing City Hospital · CN

Funding

Natural Science Foundation of Anhui Province 1708085MH214
6 · The paper itself

Abstract

objectiveVascular endothelial growth factor (VEGF) plays a critical role in regulating trophoblast cell invasion and proliferation, involved in a variety of pregnancy complications, such as spontaneous abortion and pre-eclampsia. Numerous studies have revealed that microRNAs (miRNAs) are participated in a series of molecular processes that regulate cell function, such as cell invasion, proliferation, and apoptosis. Vascular endothelial growth factor receptor 2 (VEGFR2), a receptor of VEGF, has been shown to be involved in trophoblast function. However, the relation between miRNA and VEGFR2 and their role in trophoblast function remain to be elucidated.

methodsThe effect of miR-219a on the trophoblast function has been explored using luciferase reporter, transwell, qRT-PCR, western blot, bromodeoxyuridine (BrdU), ELISA, immunofluorescent staining, and tube formation assays.

resultsIn the current study, we observed that through targeted inhibition of VEGFR2 expression by miR-219a, the function of VEGFR2 as well as the downstream PI3K/AKT/NF-κB signaling pathway were suppressed, leading to suppression of trophoblastic proliferation and invasion. Moreover, upregulation of VEGFR2 restored the miR-219a-inhibited cell proliferation, invasion, and tube formation.

conclusionsThese results revealed that miR-219a played crucial roles in negatively regulating trophoblastic proliferation and invasion by suppression of the PI3K/AKT/NF-κB signaling pathway by targeting VEGFR2, therefore serving as a potential treatment method for the complications of pregnancy caused by trophoblastic dysregulation.

Indexed as

ApoptosisCell LineCell MovementCell ProliferationFemaleHumansMicroRNAsNF-kappa BPhosphatidylinositol 3-KinasesPlacentaPre-EclampsiaPregnancyProto-Oncogene Proteins c-aktSignal TransductionTrophoblastsVascular Endothelial Growth Factor Receptor-2KDR protein, humanMicroRNAsMIRN219 microRNA, humanNF-kappa BPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktVascular Endothelial Growth Factor Receptor-2InvasionmiR-219aPI3K/AKT/NF-κB signalingProliferationTrophoblastVEGFR2

Identifiers

PMID33405003
PMCPMC7884507
OpenAlexW3118655140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.